32 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28112925	44	Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.	University of Tennessee Health Science Center
27774128	38	Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead.	Ono Pharmaceutical
25746814	80	Discovery of novel S1P2 antagonists. Part 1: discovery of 1,3-bis(aryloxy)benzene derivatives.	Ono Pharmaceutical
25100502	15	Design and synthesis of sulfamoyl benzoic acid analogues with subnanomolar agonist activity specific to the LPA2 receptor.	The University of Tennessee Health Science Center
25155385	10	Discovery of novel non-carboxylic acid 5-amino-4-cyanopyrazole derivatives as potent and highly selective LPA1R antagonists.	Hoffmann-La Roche
23395664	66	Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.	The University of Utah
22894757	69	Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.	F. Hoffmann-La Roche
18178086	26	Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents.	Amgen
20056548	4	Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.	University of Tennessee Health Science Center
19800804	19	Structure-based drug design identifies novel LPA3 antagonists.	The University of Memphis
18467108	26	Identification of non-lipid LPA3 antagonists by virtual screening.	The University of Memphis
17467986	24	Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists.	Ajinomoto
16913720	15	Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.	The University of Utah
16290140	54	Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.	University of Tennessee Health Science Center
16263282	43	Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.	University of Tennessee Health Science Center
16033271	81	Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.	University of Tennessee Health Science Center
15225728	55	A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonist.	University of Virginia
15177455	27	Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid.	Oxford University
15125924	63	Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.	University of Virginia
32584034	38	Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry.	X-Chem
31790581	23	A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA	Universidad Complutense De Madrid
31620221	6	Lysophosphatidic Acid Receptor 1 Antagonists for the Treatment of Fibrosis.	Therachem Research Medilab
22180836	5	Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonist.	University of Virginia
29259748	32	Discovery of a Slow Tight Binding LPA1 Antagonist (ONO-0300302) for the Treatment of Benign Prostatic Hyperplasia.	Ono Pharmaceutical